NPI Details
DR. Marc A Hoffing, MD is an internal medicine in Palm Springs, CA with 41 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Marc A Hoffing, MD NPI is 1972681856. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
Education
Medical School: UNIVERSITY OF ILLINOIS COLLEGE OF MED (CHI/PEOR/ROCK/CHM-URB)
Graduation Year:1985
The provider's business location address is:
275 N EL CIELO RD
PALM SPRINGS, CA
ZIP 92262-972
Phone: (760) 320-4122
Fax: (760) 320-2725
The NPI 1972681856 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)
- Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
- Fee covid-19 vac 13 res (HCPCS:0124A)
- Administration of influenza virus vaccine (HCPCS:G0008)
- Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
- Fee covid-19 vac 14 res (HCPCS:0134A)
- Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
- Adm sarscov2 30mcg/0.3ml 3rd (HCPCS:0003A)
- Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; first dose (HCPCS:0011A)
- Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
- Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; first dose (HCPCS:0001A)
The enumeration date for this NPI number is 11/1/2006 and was last updated on 7/8/2007.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 207R00000X | Internal Medicine | | G58486 | CALIFORNIA | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | E02845 | MEDICARE UPIN | CALIFORNIA | |
